UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Science (American Association for the Advancement of Science), 1996-11, Vol.274 (5291), p.1363-1366

1996

Volltextzugriff (PDF)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

The Journal of experimental medicine, 1998-11, Vol.188 (9), p.1641-1650

1998

Volltextzugriff (PDF)

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

Immunity (Cambridge, Mass.), 2000-01, Vol.12 (1), p.107-117

2000

Volltextzugriff (PDF)

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1750-1758

1998

Volltextzugriff (PDF)

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4499-4506

2000

Volltextzugriff (PDF)

Tumor Antigens Recognized by T Lymphocytes

Annual review of immunology, 1994-01, Vol.12 (1), p.337-365

1994

Volltextzugriff (PDF)

Optimum in vitro expansion of human antigen‐specific CD8+ T cells for adoptive transfer therapy

Clinical and experimental immunology, 2005-11, Vol.142 (2), p.292-302

2005

Volltextzugriff (PDF)

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

The Journal of experimental medicine, 1999-09, Vol.190 (6), p.775-782

1999

Volltextzugriff (PDF)

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases

The Journal of immunology (1950), 2001-06, Vol.166 (12), p.7634-7640

2001

Volltextzugriff (PDF)

Crystal Structures of Two Closely Related but Antigenically Distinct HLA-A2/Melanocyte-Melanoma Tumor-Antigen Peptide Complexes

The Journal of immunology (1950), 2001-09, Vol.167 (6), p.3276-3284

2001

Volltextzugriff (PDF)

CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients

European journal of immunology, 1999-06, Vol.29 (6), p.1990-1999

1999

Volltextzugriff (PDF)

An antigen-targeted approach to adoptive transfer therapy of cancer

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (9), p.2167-2173

1999

Volltextzugriff (PDF)

Cytolytic T lymphocyte recognition of the immunodominant HLA-A0201-restricted Melan-A/MART-1 antigenic peptide in melanoma

The Journal of immunology (1950), 1997-09, Vol.159 (5), p.2366-2374

1997

Volltextzugriff (PDF)

Frequent downregulation of Fas (CD95) expression and function in melanoma

Melanoma research, 2002-06, Vol.12 (3), p.263-270

2002

Volltextzugriff (PDF)

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.7253-7261

2000

Volltextzugriff (PDF)

Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients

Cancer research (Chicago, Ill.), 1997-02, Vol.57 (4), p.735-741

1997

Volltextzugriff (PDF)

Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue

The Journal of immunology (1950), 2000-01, Vol.164 (2), p.1125-1131

2000

Volltextzugriff (PDF)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

The Journal of experimental medicine, 1999-09, Vol.190 (5), p.705-716

1999

Volltextzugriff (PDF)

Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction

The Journal of immunology (1950), 2001-04, Vol.166 (7), p.4612-4619

2001

Volltextzugriff (PDF)

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A0201-associated tyrosinase peptide 368-376

Cancer research (Chicago, Ill.), 1999-08, Vol.59 (16), p.4050-4055

1999

Volltextzugriff (PDF)

Lack of BRAF mutations in uveal melanoma

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (18), p.5712-5715

2003

Volltextzugriff (PDF)

Circulating MELAN‐A/MART‐1 specific cytolytic T lymphocyte precursors in HLA‐A2+ melanoma patients have a memory phenotype

International journal of cancer, 1998-12, Vol.78 (6), p.699-706

1998

Volltextzugriff (PDF)

A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy

The Journal of immunology (1950), 2001-11, Vol.167 (10), p.5852-5861

2001

Volltextzugriff (PDF)

Peptide Modification or Blocking of CD8, Resulting in Weak TCR Signaling, Can Activate CTL for Fas- But Not Perforin-Dependent Cytotoxicity or Cytokine Production

The Journal of immunology (1950), 1998-12, Vol.161 (12), p.6939-6946

1998

Volltextzugriff (PDF)

Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression

The Journal of immunology (1950), 2000-02, Vol.164 (3), p.1148-1152

2000

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(272)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(205)
Life Sciences & Biomedicine
(198)
Animals
(178)
Humans
(174)
Mice
(152)
Immunology
(131)
T-Lymphocytes, Cytotoxic - Immunology
(105)
Biological And Medical Sciences
(90)
T-Lymphocytes - Immunology
(89)
Cytotoxicity, Immunologic
(68)
Mice, Inbred C57bl
(66)
Melanoma - Immunology
(58)
Fundamental And Applied Biological Sciences. Psychology
(53)
Neoplasm Proteins - Immunology
(50)
Fundamental Immunology
(49)
Amino Acid Sequence
(47)
Antigens, Neoplasm - Immunology
(46)
Mice, Inbred Dba
(46)
Lymphocyte Activation
(45)
Female
(44)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Tumor Antigens Recognized by T Lymphocytes

Optimum in vitro expansion of human antigen‐specific CD8+ T cells for adoptive transfer therapy

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases

Crystal Structures of Two Closely Related but Antigenically Distinct HLA-A2/Melanocyte-Melanoma Tumor-Antigen Peptide Complexes

CD28‐negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients

An antigen-targeted approach to adoptive transfer therapy of cancer

Cytolytic T lymphocyte recognition of the immunodominant HLA-A0201-restricted Melan-A/MART-1 antigenic peptide in melanoma

Frequent downregulation of Fas (CD95) expression and function in melanoma

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients

Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A0201-associated tyrosinase peptide 368-376

Lack of BRAF mutations in uveal melanoma

Circulating MELAN‐A/MART‐1 specific cytolytic T lymphocyte precursors in HLA‐A2+ melanoma patients have a memory phenotype

A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy

Peptide Modification or Blocking of CD8, Resulting in Weak TCR Signaling, Can Activate CTL for Fas- But Not Perforin-Dependent Cytotoxicity or Cytokine Production

Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression

Suchergebnisse filtern